Graham Doyle

Stock Analyst at UBS

(2.22)
# 2,738
Out of 5,114 analysts
11
Total ratings
80%
Success rate
5.42%
Average return

Stocks Rated by Graham Doyle

Fresenius Medical Care AG
Sep 2, 2025
Downgrades: Sell
Price Target: n/a
Current: $23.51
Upside: -
GE HealthCare Technologies
May 5, 2025
Upgrades: Neutral
Price Target: $74$73
Current: $82.89
Upside: -11.93%
Smith & Nephew
Mar 12, 2025
Downgrades: Neutral
Price Target: n/a
Current: $32.82
Upside: -
Koninklijke Philips
Feb 20, 2025
Upgrades: Buy
Price Target: n/a
Current: $26.66
Upside: -